Search Bar & Filters
Found 5 Actively Recruiting clinical trials
Actively Recruiting
Researchers are gathering real-world data on the outcomes of patients with perimembranous ventricular septal defects PmVSD, a heart condition, who have undergone transcatheter closure using various device occluders. This international, multicenter, non-interventional, observational study aims to evaluate how well these devices work and their safety when used in both children and adults. The study focuses on patients treated with devices either specifically designed for PmVSD closure or used off-label. Participants in this study have had their PmVSD closed using commercially available occluder devices through a transcatheter procedure. The devices are placed without open-heart surgery to close the defect. The study observes patients who have already undergone this procedure and collects follow-up data according to each hospitals usual practice. The study does not intervene but monitors how these devices perform over time. Participants will be followed for up to 60 months after their procedure to assess clinical success, technical success, closure success, and any device-related complications. Researchers will also evaluate functional outcomes and quality of life for up to 48 months post-procedure. Data collection includes clinical events from the implant attempt through the follow-up period, and safety is monitored by tracking adverse events. The total duration of participation depends on the timing of the procedure and follow-up visits according to local protocols.
Actively Recruiting
Researchers are evaluating the use of caffeine citrate in late-preterm infants who experience respiratory distress. The study aims to understand whether caffeine can improve breathing effort, reduce apnea episodes, shorten hospital stays, and improve alertness in babies born between 34 and 36 67 weeks of gestation. This is a controlled trial comparing caffeine therapy to placebo in this vulnerable population. Participants are randomly assigned to receive either caffeine citrate or a placebo in a double-blind manner. The caffeine group receives a loading dose of 20 mgkg equivalent to 10 mgkg caffeine base followed by a maintenance dose of 10 mgkgday equivalent to 5 mgkg caffeine base. Treatment continues until the infant no longer needs any respiratory support. The placebo group receives an equivalent volume of saline. Preparation and administration of the study drugs are handled by a pharmacist not involved in the study to maintain blinding. During the 28-day study period, infants will be closely monitored for duration of respiratory support, episodes and days of apnea, extubation failure, length of hospital stay, feeding progress, weight gain, and any adverse effects from caffeine use. Researchers will also track readmission rates and mortality. Assessments include clinical observations and routine care measures to evaluate the overall impact of caffeine on respiratory health and recovery in late-preterm infants.
Actively Recruiting
This research investigates the effects of two types of cardiac rehabilitation programs on patients with coronary artery disease who have undergone coronary artery bypass grafting surgery. The study aims to compare high-intensity interval training HIIT with a home-based cardiac rehabilitation program to see how each affects peak metabolic equivalents, which reflect exercise capacity, after surgery. The study also assesses functional outcomes between these treatment approaches to improve recovery and physical activity post-surgery. Participants are randomly assigned to one of three groups one group receives a four-week high-intensity interval training program involving treadmill or leg ergo-cycle exercises with structured warm-up, high-intensity intervals, recovery periods, and cool-down phases another group follows a four-week home-based cardiac rehabilitation program using Physio-tools software, exercise logging, a Polar watch, and weekly phone support for moderate-intensity circuit training three times per week the control group receives standard care with an instruction booklet about surgery, wound care, and encouragement to stay active. Throughout the study, participants undergo assessments of exercise capacity at the start and after four weeks to measure the impact of the rehabilitation programs. Researchers monitor safety and functional outcomes, with the overall goal of evaluating how these rehabilitation methods influence cardiopulmonary fitness and physical activity after surgery. The study is led by Kafrelsheikh University and includes adults aged 55 to 58 who are clinically stable and meet risk stratification criteria.
Actively Recruiting
Healthy Volunteer
Researchers are evaluating the safety of different phototherapy stopping points in newborns with hemolytic disease. The study compares a lower threshold versus a higher threshold for stopping phototherapy based on total serum bilirubin TSB levels. The goal is to see which approach reduces the chance of rebound high bilirubin after treatment in term and late preterm infants with this condition. Neonates in the low-threshold group will stop phototherapy when their TSB is about 100 micromolL below the American Academy of Pediatrics AAP threshold. Those in the high-threshold group will stop when TSB is 50 to 100 micromolL below the AAP threshold. Phototherapy is started for both groups according to AAP guidelines, using intensified blue LED lights when TSB reaches treatment levels. Some infants may receive immunoglobulin or exchange transfusions if bilirubin levels are very high or if clinical signs appear. Parents and caregivers can expect close monitoring of their infants through hospital stays, including TSB blood tests and clinical checks. Researchers will track outcomes like rebound high bilirubin within 28 days, length of hospital stay, and any side effects from phototherapy. The study also follows cost of neonatal intensive care over 90 days. Participation lasts during the newborn period with follow-up to assess safety and treatment results.
Actively Recruiting
Breast cancer is the most common cancer affecting women worldwide, and early-stage breast cancer is typically treated with breast-conserving surgery and sentinel lymph node biopsy to minimize surgical impact while ensuring complete tumor removal and accurate staging. This study evaluates the use of Super Paramagnetic Iron Oxide SPIO, specifically Magtrace, as a single agent for both bracketing the tumor area and localizing the sentinel lymph node. The goal is to test whether this dual-purpose approach is feasible and effective compared to current methods that use multiple localization tools. Participants who need bracketing for wide local excision along with sentinel lymph node biopsy will receive Magtrace injections at four points around the tumor area one day before surgery under ultrasound or mammographic guidance. On the day of surgery, surgeons will use a magnetic probe to locate the Magtrace signal for both the lesion and sentinel lymph node. If localization fails, alternative methods may be used. Surgery will follow standard techniques, and a blue dye will also be used to confirm sentinel node detection. The study aims to recruit 35 patients for this prospective pilot trial. During the study, participants will undergo localization procedures before surgery, surgical excision, and sentinel node biopsy with ongoing monitoring of localization success, surgical duration, tissue removal, margin status, reoperation rates, and postoperative complications up to three months. Data on clinical outcomes, complications, and cost will be collected and analyzed. The study will last approximately 2 to 3 years, including recruitment and follow-up, with results intended for publication and broader sharing.